Jeff Cohen
Stock Analyst at Ladenburg Thalmann
(2.66)
# 2,023
Out of 4,859 analysts
12
Total ratings
54.55%
Success rate
18.93%
Average return
Main Sectors:
Stocks Rated by Jeff Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NMTC NeuroOne Medical Technologies | Initiates: Buy | $1.45 | $0.57 | +152.61% | 1 | May 5, 2025 | |
| CBLL CeriBell | Initiates: Buy | $32 | $18.17 | +76.11% | 1 | Apr 4, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $31 | $19.49 | +59.06% | 1 | Feb 20, 2025 | |
| LGCY Legacy Education | Maintains: Buy | $9.1 → $11 | $8.99 | +20.13% | 2 | Feb 14, 2025 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $3.70 | - | 1 | Nov 15, 2024 | |
| SNOA Sonoma Pharmaceuticals | Initiates: Buy | $65 | $3.16 | +1,956.96% | 1 | Sep 5, 2023 | |
| DKNG DraftKings | Initiates: Overweight | $52 | $37.98 | +36.91% | 1 | Jul 1, 2020 | |
| SE Sea Limited | Initiates: Overweight | $130 | $154.63 | -15.93% | 1 | Jul 1, 2020 | |
| TTWO Take-Two Interactive Software | Maintains: Equal-Weight | $110 → $130 | $234.46 | -44.55% | 3 | May 21, 2020 |
NeuroOne Medical Technologies
May 5, 2025
Initiates: Buy
Price Target: $1.45
Current: $0.57
Upside: +152.61%
CeriBell
Apr 4, 2025
Initiates: Buy
Price Target: $32
Current: $18.17
Upside: +76.11%
Beta Bionics
Feb 20, 2025
Initiates: Buy
Price Target: $31
Current: $19.49
Upside: +59.06%
Legacy Education
Feb 14, 2025
Maintains: Buy
Price Target: $9.1 → $11
Current: $8.99
Upside: +20.13%
Bionano Genomics
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.70
Upside: -
Sonoma Pharmaceuticals
Sep 5, 2023
Initiates: Buy
Price Target: $65
Current: $3.16
Upside: +1,956.96%
DraftKings
Jul 1, 2020
Initiates: Overweight
Price Target: $52
Current: $37.98
Upside: +36.91%
Sea Limited
Jul 1, 2020
Initiates: Overweight
Price Target: $130
Current: $154.63
Upside: -15.93%
Take-Two Interactive Software
May 21, 2020
Maintains: Equal-Weight
Price Target: $110 → $130
Current: $234.46
Upside: -44.55%